Hypershell secures an additional $50 million in a $120 million Series B round as consumer exoskeletons move beyond their niche market.

      Ant Group and Meituan Dragonball jointly led a $50 million Series B+ funding round for Hypershell, with Sofina and Granite Asia also participating. The total amount raised in the Series B now reaches $120 million, with a post-money valuation nearing $400 million, just ahead of the global launch of the X-Series on Wednesday.

      Hypershell, the Shanghai-based consumer exoskeleton firm, secured $50 million in a Series B+ funding round co-led by Ant Group and Meituan Dragonball (referred to as DragonBall Capital in the announcement), along with contributions from Sofina and Granite Asia. The financial advisory for this round was exclusively handled by Cygnus Equity.

      This funding round marks the second portion of the Series B, bringing the company's total funding to $120 million, with a valuation approaching $400 million, as confirmed by Yicai Global.

      The timing of this funding round is noteworthy. According to Hypershell's own reports, the broader Series B was raised within a twelve-month timeframe: $70 million from pre-B and B rounds in November 2024, led by Luminous Ventures and 5Y Capital, followed by the current $50 million Series B+.

      This timeline indicates that Ant Group and Meituan Dragonball invested at a crucial moment when Hypershell’s unit economics transitioned from demonstrating product-market fit to proving scalability.

      Hypershell claims its X series is the first consumer exoskeleton to lead on Amazon in both sales volume and market share in the U.S. and Europe.

      The financing's product narrative has been evident since 2023, when Hypershell launched its first consumer-grade exoskeleton on Kickstarter, garnering over $1.23 million from 2,638 backers.

      The initial model translated exoskeleton engineering from the medical and industrial sectors into a consumer-friendly device weighing under 2 kg, targeted at hikers, travelers, athletes, and users with mobility challenges.

      Independent reviews, including those from Fast Company’s gear desk, have validated the product’s claims of reducing physical exertion by 30% and enhancing effective leg strength by approximately 40%.

      The new product, the New Hypershell X Series, is set to launch globally on Wednesday, May 20, at 13:00 BST. Its prominent technical highlight is HyperIntuition, a proprietary AI motion-control algorithm that Hypershell describes as evolving beyond preset movement patterns to a closed-loop perception-recognition-prediction-planning system capable of interpreting user intent in real time.

      Additionally, Hypershell's series is recognized as the first end-to-end consumer exoskeleton validated by TÜV Rheinland, positioning the company to signal quality assurance as it targets mass-market sales channels.

      Founded in 2021 by Kelvin Sun, an engineer known for the hardware venture Lattepanda, Hypershell operates with a team of around 100 staff across Beijing and Shenzhen. Sun stated, "Hypershell started with a simple idea: help people go farther," highlighting the company’s reach into over 70 countries since its inception.

      The mix of strategic investors suggests future directions for Hypershell. Ant Group serves as Alibaba's consumer-data and payment division, while Meituan Dragonball represents the early-stage venture wing of superapp Meituan. Both entities offer distribution strength, with Ant’s Alipay and Meituan’s logistics enhancing Hypershell's access to the challenging Chinese consumer market. Sofina and Granite Asia provide continuity from the existing traction in Western retail.

      The competitive landscape is shaped by China’s broader push into robotics, projected to escalate through 2026. Barclays recently estimated that humanoid robots could help counteract a projected decline of 37 million workers in China’s labor force by 2035.

      Hypershell operates in a different segment compared to the humanoid robotics race: While Unitree's GD01 and its $7 billion IPO represent investments in bipedal humanoids, consumer exoskeletons are aimed at augmenting human capabilities rather than replacing them. These two categories compete for separate budgets yet share overlapping investor stories.

      The press release does not address the ongoing concerns regarding customer satisfaction versus supply challenges faced by the broader Chinese consumer-robotics sector.

      Independent assessments on the humanoid side report buyer satisfaction at only 23% among over 150 active manufacturers. Hypershell's claim to lead on Amazon provides a significant counterpoint to that trend. However, the upcoming New X Series launch will be the first product introduction supported by both the new capital and strategic distribution partners, making the next two quarters critical for determining whether Hypershell can achieve large-scale success with this launch.